The sales of respiratory system medicine in Italy are forecasted to show a stable growth trend from 2024 to 2028, with an increase from 25.6 to 25.8 US Dollars per capita. The year-on-year variation is minimal, indicating a steady market with moderate growth. The compound annual growth rate (CAGR) is expected to underline this consistent growth over the five-year forecast period.

Future trends to watch include:

Potential advances in respiratory therapies and treatments.
The impact of demographic changes, such as an aging population, on respiratory medicine demand.
Policy changes related to healthcare funding and drug accessibility.
Ongoing effects of environmental factors, such as air quality, on respiratory health.